GGrantIndex
← Leaderboards

Jose G. Trevino

University Of Florida

$1,634,251
Attributed
$3,541,861
Total exposure
4
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY201825
$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,860,732 · 6

By mechanism

U54$3,914,610 · 4
R01$2,607,294 · 1
R41$338,828 · 1

Most similar at University Of Florida

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Malignant Neoplasm Of Pancreas

Research focus

Malignant Neoplasm Of PancreasMalignant NeoplasmsResponseMediatingTumorMalignant Breast NeoplasmInnovationPharmaceutical PreparationsHealth EquityClinical TrialsPatient Derived Xenograft ModelGemcitabineUnderrepresented MinorityTissuesNeoplastic CellTreatment EfficacyChemotherapeutic AgentPlayCancer CellChemotherapyPathway InteractionsProteinsDesignNeoplasm Metastasis

Grant awards (18)

United for Health Equity - Living PDX Program (U4HELPP)$1,003,591
U54 · FY2025 · CA · contact PI
Administrative Core$112,321
U54 · FY2025 · CA · contact PI
United for Health Equity - Living PDX Program (U4HELPP)$960,065
U54 · FY2024 · CA · contact PI
Precision medicine for pancreatic cancer. Biomarker-guided drug delivery of platinum to tumors$338,828
R41 · FY2024 · CA
United for Health Equity - Living PDX Program (U4HELPP)$131,820
U54 · FY2024 · CA · contact PI
Administrative Core$91,701
U54 · FY2024 · CA · contact PI
United for Health Equity - Living PDX Program (U4HELPP)$1,030,960
U54 · FY2023 · CA · contact PI
Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancer$515,151
R01 · FY2023 · CA
Administrative Core$98,854
U54 · FY2023 · CA · contact PI
Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancer$515,151
R01 · FY2022 · CA
Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancer$525,664
R01 · FY2021 · CA
Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancer$525,664
R01 · FY2020 · CA
Investigations of Black Ancestry on Pancreatic Cancer Tumor Biology for US-related Cancer Health Disparities$192,435
U54 · FY2020 · CA
Project 2: Enhancing Efficacy of Gemcitabine Nanoparticles in Pancreatic PDX Models$103,709
U54 · FY2020 · CA · contact PI
Use of BCL-xL Proteolysis targeting chimeras to treat pancreatic cancer$525,664
R01 · FY2019 · CA
Project 2: Enhancing Efficacy of Gemcitabine Nanoparticles in Pancreatic PDX Models$82,472
U54 · FY2019 · CA · contact PI
Project 2: Enhancing Efficacy of Gemcitabine Nanoparticles in Pancreatic PDX Models$21,796
U54 · FY2019 · CA · contact PI
Project 2: Enhancing Efficacy of Gemcitabine Nanoparticles in Pancreatic PDX Models$84,886
U54 · FY2018 · CA · contact PI